NASDAQ : MNOV
MediciNova, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 68.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 68.91M |
| Enterprise Value | 43.61M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 49.22M |
| Shares Outstanding | 49.22M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.87% |
| Owned by Institutions (%) | 10.56% |
| Float | 42.94M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 74.86 |
| Forward PS | 826.95 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 3.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 47.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.75 |
| Quick Ratio | 8.58 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -25.56% |
| Return on Assets (ROA) | -16.41% |
| Return on Invested Capital (ROIC) | -17.52% |
| Return on Capital Employed (ROCE) | -31.62% |
| Weighted Average Cost of Capital (WACC) | 7.62% |
| Revenue Per Employee | $153,414 |
| Profits Per Employee | -$1.79M |
| Employee Count | 6 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 5,994 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +18.64% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 38.44 |
| Average Volume (20 Days) | 74,903 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 292,306 |
| Short Previous Month | 339,114 |
| Short % of Shares Out | 0.59% |
| Short % of Float | 0.68% |
| Short Ratio (days to cover) | 0.35 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 920,481 |
| Gross Profit | 347,443 |
| Operating Income | -11.85M |
| Pretax Income | -10.75M |
| Net Income | -10.75M |
| EBITDA | -11.83M |
| EBIT | -11.85M |
| Loss Per Share | -$0.22 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 25.42M |
| Total Debt | 117,038 |
| Net Cash | 25.30M |
| Net Cash Per Share | $0.51 |
| Equity (Book Value) | 37.27M |
| Book Value Per Share | 0.76 |
| Working Capital | 22.96M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -9.11M |
| Capital Expenditures | -13,724 |
| Depreciation & Amortization | 19,138 |
| Net Borrowing | n/a |
| Free Cash Flow | -9.12M |
| FCF Per Share | -$0.19 |
Margins
| Measure | Value |
|---|
| Gross Margin | 37.75% |
| Operating Margin | -1,287.41% |
| Pretax Margin | -1,167.55% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.21% |
| Shareholder Yield | -0.21% |
| Earnings Yield | -15.63% |
| FCF Yield | -13.24% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.25 |
| Price Target Difference | 489.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 370.58% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.69 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |